Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 31
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparative inflammatory and immune effects of pollution in asthmatics and healthy subjects

  • Soler Segovia, David
  • Romero Mesones, Christian
  • Espejo Castellanos, David
  • Pilia, F.
  • Ojanguren, Iñigo|||0000-0003-1270-5772
  • Martínez, C.
  • Muñoz Gall, Francisco Javier|||0000-0002-8693-022X
  • Cruz, María Jesús|||0000-0001-9759-5466
Introduction: The objective of this study was to assess the inflammatory and immunological responses in asthmatic patients and healthy controls exposed to a polluted or a non-polluted environment during a short-term period. Material and methods: Randomized crossover study in patients with asthma (n = 20), and in healthy controls (n = 15). Participants were exposed for 2 hours to a polluted environment and, after 14 days, to a non-polluted environment. At each exposure, pollution levels were assessed. Subsequently, serum levels of 8-isoprostane and glutathione peroxidase were measured as markers of oxidative stress as well as 48 inflammatory and immune response cytokines. Results: In the polluted environment, significantly higher levels of PM1, PM10, NO2, NO and CO were observed (p=0.0026, 0.0337, <0.0001, <0.0001 and 0.0004 respectively) than in the non polluted environment. After exposure to a polluted environment, both groups (healthy controls and asthmatic patients) presented higher values of IL17F (p= 0.0285 and 0.0348 respectively) and CSF2 (p= 0.0425 and 0.0305 respectively). Healthy controls presented reductions in glutathione peroxidase (with antioxidant activity) (p=0.0038), CSF3, HGF and OSM (p= 0.0123, 0.0353 and 0.0256 respectively) and increased levels of IL7, CXCL8 and CCL2 (p= 0.0015, 0.0119 and 0.0215 respectively) after exposure to high levels of pollution. Asthmatic patients had higher serum levels of IL1b and IL15 (p= 0.0232 and 0.0497 respectively). Conclusion: Healthy individuals and asthmatics present different responses to exposure to pollutants. In healthy individuals, there is an adaptive suppression of immune activity. Conversely, asthmatics present a more marked inflammatory response.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring a circulating miRNA signature for PMM2-CDG: Initial insights toward diagnosis, stratification, and monitoring

  • Epifani, Florencia
  • Cabus, Lluc|||0000-0003-3068-4135
  • Nolasco, Gregorio A.
  • Bolasell, Mercè
  • Pérez, Jennifer
  • Alcalá, Adrián
  • Fernández, Patricia
  • Lizano, Esther|||0000-0003-3304-9807
  • Márquez, Gisela
  • Belmonte, Sonia
  • Carbonell-Sala, Sílvia
  • Lagarde, Julien
  • Curado, Joao
  • Hernando Davalillo, Cristina
  • Serrano, Mercedes|||0000-0002-2056-2428
Phosphomannomutase deficiency (PMM2-CDG) is the most common congenital disorder of glycosylation, characterized by variable early-onset neurological (hypotonia, cerebellar syndrome, developmental delay) and multi-organ manifestations. Although several clinical trials are ongoing, current biomarkers lack prognostic or monitoring utility. Emerging transcriptomic studies suggest dysregulated pathways in PMM2-CDG, but miRNAs, key gene expression regulators, remain unexplored. This cross-sectional study aims to investigate a circulating miRNA signature that may distinguish PMM2-CDG patients from unaffected controls, providing an initial framework for future studies on potential predictive and monitoring tools. Differential gene expression analysis was used to identify significant differentially expressed (DE) miRNAs, while machine learning models (LASSO, XGBoost) were applied to create an miRNA predictive signature. Dysregulated miRNA pathways analysis provided insights into affected tissues and cellular mechanisms. An optimized protocol addressing challenges in pediatric blood samples was implemented. miRNA profiles from blood samples of 28 PMM2-CDG patients and 67 unaffected controls were analyzed, identifying six DE miRNAs. Regarding machine learning models, XGBoost achieved the best performance (AUC 0.917). Biological analysis revealed that DE miRNAs influence neurological, endocrinological, immunological, and cellular pathways related to the PMM2-CDG phenotype. Notably, miR-122-5p emerged as a highly predictive marker, indicating liver and neurological involvement. Circulating miRNAs represent a promising, minimally invasive avenue for further investigation. While preliminary evidence of their potential diagnostic utility is provided, additional validation in larger and more diverse populations is required to determine their relevance for clinical stratification or monitoring in PMM2-CDG, contributing to future biomarker-driven personalized medicine efforts in this disease.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Decoding the antiviral potential of eugenol, thymol and vanillin against human cytomegalovirus infection

  • Martin-Martin, Clara
  • Ruiz Rico, María
  • Garcia-Rios, Estefani
  • Romero, Pilar Perez-
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
[EN] Human cytomegalovirus (HCMV) poses serious health risks, particularly for immunocompromised individuals. However, the current FDA-approved anti-HCMV drugs face challenges such as drug resistance and significant side effects, underscoring the need for alternative treatment options. Essential oil components (EOCs), including eugenol, thymol and vanillin, are recognized for their therapeutic potential. This study evaluates their antiviral effects against HCMV in epithelial (ARPE-19) and fibroblast (MRC-5) cell lines. Among the EOCs, vanillin demonstrated the highest efficacy, characterized by low toxicity and a high selectivity index in both cell types. Mechanistic differences were noted between the cell lines. In ARPE-19 cells, eugenol showed virucidal activity, inhibited viral entry and suppressed early gene expression (IE-1). Conversely, in MRC-5 cells, eugenol mainly blocked viral entry and exhibited virucidal effects. Thymol was most effective in ARPE-19 cells, where it completely suppressed IE-1 expression as a result of both inhibition of viral entry and a direct disruptive effect on IE-1 expression. In addition, thymol showed an effect on viral replication. In MRC-5 cells, thymol primarily inhibited viral entry and attachment. Vanillin exhibited dual inhibitory activity in both cell lines, blocking viral attachment and entry. In MRC-5, vanillin also appears to affect intermediate processes. Notably, combining EOCs with ganciclovir resulted in synergistic effects. The eugenol/ganciclovir combination was particularly effective in ARPE-19 cells, while thymol/ganciclovir showed enhanced efficacy in MRC-5 cells. These findings suggest that EOCs have significant potential as adjunct therapies to improve antiviral outcomes and address drug-resistant HCMV strains., This study was supported by the Spanish Ministry of Science, Innovation and University, Instituto de Salud Carlos III Grant/Award Numbers: PI20CIII-00009 (MPY303/20) and PID2021- 128141OB- C21 funded by MCIN/AEI/10.13039/501100011033, by 'ERDF A way of making Europe' and by the Start-up Research Grant University Notre Dame. C.M.-M. is supported by the PFIS Program (FI22CIII/0029) , Instituto de Salud Carlos III, Ministerio de Ciencia, Innovacion y Universidades. E.G.-R. was supported by the Generalitat Valenciana plan GenT grant no. CIDEIG/2022/028.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

  • Grau-Perez, Maria
  • Martinez-Arroyo, Olga
  • Rubia-Martinez, Marta
  • Flores-Chova, Ana
  • Rodríguez-Hernández, Zulema
  • Fernández-Navarro, Pablo
  • Gonzalez-Neira, Anna
  • Alonso, María Rosario
  • Pita, Guillermo
  • Pineda, Silvia
  • Martin-Escudero, Juan C.
  • Redon, Josep
  • Tellez-Plaza, Maria
  • Cortes, Raquel
  • Guasque Ortega, Ana|||0000-0002-2900-8466
[EN] Background: Circulating microRNAs (miRNAs) are emerging markers for cardiovascular prevention and control. miRNAs associated to vascular damage are candidates to play a causal role in the microvascular dysfunction of heart failure (HF). The aim was to evaluate the observational and causal (Mendelian randomization) association of miRNAs related with vascular alterations (miR-126-3p, miR-1260b and miR-374a-5p) with HF incidence in a sample from the general population. Methods: Plasma miRNAs levels were measured in 985 Hortega Study participants using real time quantitative polymerase chain reaction (RT-qPCR). Single nucleotide polymorphisms (SNPs) were genotyped with the TOPMED imputable Illumina GSA array. We identified genetic instrumental variables for miR-126-3p (33 SNPs), miR-1260b (22 SNPs) and miR-374a-5p (35 SNPs) and run several Mendelian randomization approaches. Results: The hazard ratio (95 % confidence interval) of HF by a 10-fold increase in miR-126-3p, miR-1260b and miR-374a-5p was 1.53 (1.09, 2.14), 1.38 (1.03, 1.86), and1.30 (1.09, 1.57), respectively. The corresponding rate differences were 9.7 (-0.1, 19.5), 12.0 (0.4, 23.6) and 9.1 (1.2, 17.1) per 10000 person-years. In flexible dose-response analysis, increased miRNAs levels were associated with higher HF risk, both in the relative and additive scale. In Mendelian randomization analysis, consistently suggestive positive causal associations were found with HF for increased miR-126-3p and miR-1260b levels, but not for miR-374a-5p. Conclusions: In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associ-ated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control., We thank Nuria Alvarez y Belen Herraez, from the Human Genotyping-CEGEN Unit, at the National Center for Cancer Research from the Carlos III Health Institutes, in Madrid (Spain) , for their contribution in the genotyping procedure. This research was funded by health sciences research grants from the Carlos III Health Institute (grant numbers PI19/01796 to J.R.; PI21/00249 and CP22/00069 to R.C.; PI23/01179 to A.O.; FI20/00096 to O.M.-A; and FI22/00032 to A.F.-C.; PI15/00071 and PI22CIII/00029 to M.T.-P.) . This work was also sup-ported by the State Agency for Research (PID2019-108973RB-C21 to M. T.-P.) . Grant IJC2020-045308-I, Juan de la Cierva Incorporacion funded by MCIN/AEI/10.13039/501100011033 and by ESF-Investing in Your Future (to A.O.) ; CNS2022-136175, Research Consolidation Grants, funded by MCIN/AEI/10.13039/501100011033 and European Union "Next Generation EU"/PRTR" (to R.C) .; FP7-HEALTH 11 (grant number no 278249) . It was co-funded by the European Union (the European Regional Development Fund (ERDF) and the European Social Fund (FSE) ) ; CIBER of Obesity and Nutrition Physiopathology (CIBEROBN) (grant numbers CIBER-02-08-2009, CB06/03 and CB12/03/30016) . CIBER of Cardiovascular diseases (CIBERCV) (grant number CB16/11/00261) . CIBEROBN and CIBERCV are co-funded with European Funds for Regional Development (FEDER) , and IDIFEDER/2021/072, CIAICO/2022/181 and INVEST/2023/180 from the Generalitat Valenciana of Spain. Z.R.-H. received a fellowship associated to a Spain National Investigation Agency project (PRE2020-093926) . The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish Na-tional Cancer Research Centre (CNIO) , supported by Instituto de Salud Carlos III (ISCIII) , Ministerio de Ciencia e Innovacion. CEGEN is part of the initiative IMPaCT GEN oMICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Primary human hepatocyte-laden scaffolds for the treatment of acute liver failure

  • Rodríguez-Fernández, Julio
  • Garcia-Legler, Emma
  • Villanueva-Badenas, Estela
  • Donato, M. Teresa
  • Salmerón Sánchez, Manuel
  • Tolosa, Laia
  • Gómez Ribelles, José Luís|||0000-0001-9099-0885
  • Gallego-Ferrer, Gloria|||0000-0002-2428-0903
[EN] Cell-based liver therapies based on retrieving and steadying failed metabolic function(s) for acute and chronic diseases could be a valuable substitute for liver transplants, even though they are limited by the low engraftment capability and reduced functional quality of primary human hepatocytes (PHH). In this paper we propose the use of gelatin-hyaluronic acid (Gel-HA) scaffolds seeded with PHH for the treatment of liver failure. We first optimized the composition using Gel-HA hydrogels, looking for the mechanical properties closer to the human liver and determining HepG2 cells functionality. Gel-HA scaffolds with interconnected porosity (pore size 102 ¿m) were prepared and used for PHH culture and evaluation of key hepatic functions. PHH cultured in Gel-HA scaffolds exhibited increased albumin and urea secretion and metabolic capacity (CYP and UGT activity levels) compared to standard monolayer cultures. The transplant of the scaffold containing PHH led to an improvement in liver function (transaminase levels, necrosis) and ameliorated damage in a mouse model of acetaminophen (APAP)-induced liver failure. The study provided a mechanistic understanding of APAP-induced liver injury and the impact of transplantation by analyzing cytokine production and oxidative stress induction to find suitable biomarkers of cell therapy effectiveness., This work has been supported by the Institute of Health Carlos III (Plan Estatal de I+D+i 2013-2016) and co-financed by the European Regional Development Fund "A way to achieve Europe" (FEDER) through grants PI18/00993, PI21/00223 and CP16/00097; by the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033 through the PID2019-106000RB-C21 and PID2019-106000RB-C22 Grants and by the Generalitat Valenciana (PROMETEO/2019/060) . L.T. was supported by ISCIII CP16/00097 and MV21/00044, E.V.B through grant FI22/00082 (ISCIII) . M.S-S was supported by an EPSRC Programme Grant (EP/P001114/1).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: a mediation analysis

  • Clougher, Derek
  • G Segura, Àlex
  • Forte, María Florencia
  • Mezquida, Gisela
  • Cuesta, Manuel J.
  • Vieta, Eduard
  • Amoretti, Silvia
  • Lobo, Antonio
  • González-Pinto, Ana
  • M. Díaz-Caneja, Covadonga
  • Roldán, Alexandra
  • Fico, Giovanna
  • de la Serna, Elena
  • Bergé, Daniel
  • Gassó, Patricia
  • Rodriguez, Natalia
  • Verdolini, Norma
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ribasés, Marta
  • Bernardo, Miguel
  • Mas, Sergi
Background: Polygenic risk scores for educational attainment (PRSEA), cognitive reserve (CR), and clinical symptoms are associated with psychosocial functioning in first-episode psychosis (FEP). Nevertheless, the mechanisms underlying their complex interaction is yet to be explored. This study aimed to assess the mediating role of CR and clinical symptoms, both negative (NS) and positive (PS), on the interrelationship between PRSEA and functionality, one year after a FEP. Methods: A total of 162 FEP patients underwent clinical, functional, and genetic assessments. Using genome-wide association study (GWAS) summary results, PRSEA were constructed for each individual. Two mediation models were explored. The parallel mediation model explored the relationship of PRSEA with functionality through CR and clinical symptoms, NS, and PS. The serial mediation model tested a causal chain of the three mediators: CR, NS and PS. Mediation analysis was performed using the PROCESS function V.4.1 in SPSS V.22. Results: A serial mediation model revealed a causal chain for PRSEA > CR > NS > Functionality (β=-0.35, 95%CI [-0.85, -0.04], p<0.05). The model fit the data satisfactorily (CFI=1.00; RMSEA=0.00; SRMR=7.2x10-7). Conversely, in a parallel mediation, none of the three mediators significantly mediated the relationship between PRSEA and functionality and the model poorly fit the data (CFI=0.30; RMSEA=0.25; SRMR=0.11). Conclusions: Both CR and NS mediate the relationship between PRSEA and functionality at oneyear follow-up, using serial mediation analysis. This may be relevant for prevention and personalized early intervention to reduce illness impact and improve functional outcomes in FEP patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Antimicrobial Photodynamic Therapy Using Encapsulated Protoporphyrin IX for the Treatment of Bacterial Pathogens

  • Izquierdo, Natalia
  • Gamez, Enrique
  • Alejo, Teresa
  • Mendoza, Gracia
  • Arruebo, Manuel
Herein, we report on the antimicrobial photodynamic effect of polymeric nanoparticles containing the endogenous photosensitizer protoporphyrin IX. Compared to equivalent doses of the free photosensitizer, we demonstrated that the photodynamic antimicrobial efficacy of PLGA (polylactic-co-glycolic acid) nanoparticles containing protoporphyrin IX (PpIX) against pathogenic Staphylococcus aureus (S. aureus) is preserved after encapsulation, while photobleaching is reduced. In addition, compared to equivalent doses of the free porphyrin, we show that a reduction in the cytotoxicity in mammalian cell cultures is observed when encapsulated. Therefore, the encapsulation of protoporphyrin IX reduces its photodegradation, while the released photosensitizer maintains its ability to generate reactive oxygen species upon light irradiation. The polymeric nanoencapsulation promotes aqueous solubility for the hydrophobic PpIX, improves its photostability and reduces the cytotoxicity, while providing an extended release of this endogenous photosensitizer.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Forte, María Florencia
  • Mezquida, Gisela
  • Sánchez-Torres, Ana M.
  • Serra-Navarro, María
  • Penadés, Rafael
  • Lobo, Antonio
  • González Pinto, Ana
  • Panadero, Rocío
  • Roldán, Alexandra
  • Vieta, Eduard
  • de la Serna, Elena
  • Trabsa, Amira
  • Martínez-Arán, Anabel
  • Torrent, Carla
  • Tortorella, Alfonso
  • Menculini, Giulia
  • Ramos-Quiroga, Josep Antoni
  • Cuesta, Manuel J.
  • Bernardo, Miquel
  • Amoretti, Silvia
  • Salmerón, Sergi
  • Arbelo, Néstor
  • Ferrer-Quintero, Marta
  • Echevarría, Ana
  • Selma, Judit
  • Grasa, Eva Ma
  • Marin, Julen
  • Mar, Lorea
  • De la Cámara, Concepción
  • Ruíz-Lázaro, Pedro M
  • Nacher, Juan
  • Nicolas, Carlos Cañete
  • Mané, Anna
  • Toll, Alba
  • Solé, Brisa
  • Mallorqui, Aida
  • Castro-Fornieles, Josefina
  • Baeza, Inmaculada
  • Contreras, Fernando
  • Sáiz, Pilar A.
  • Bobes-Bascarán, Teresa
  • Segarra, Rafael
  • Zabala, Arantzazu
  • Scala, Mauro
  • Rodriguez-Jimenez, Roberto
  • Usall, Judith
  • Butjosa, Anna
  • Pomarol-Clotet, Edith
  • García-León, Maria Ángeles
  • Ibañez, Angela
  • Moreno-Izco, Lucía
  • Balanzá-Martínez, Vicent
Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial

  • Castells, Antoni
  • Quintero, Enrique
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Cubiella, Joaquín
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Akiko, Ono
  • Serra-Burriel, Miquel
  • Frías-Arrocha, Eladio
  • Hernández, Cristina
  • Jover, Rodrigo
  • Andreu, Montserrat
  • Carballo, Fernando
  • Morillas, Juan Diego
  • Salas, Dolores
  • Almazán, Raquel
  • Alonso-Abreu, Inmaculada
  • Banales, Jesús M.
  • Hernández, Vicent
  • Portillo, Isabel
  • Vanaclocha-Espí, Mercedes
  • Vega, Mariola de la
  • COLONPREV study investigators
Background: Colonoscopy and the faecal immunochemical test are accepted strategies for colorectal cancer screening in the average-risk population (ie, people aged ≥50 years without personal or family history of colorectal cancer). In this trial, we aimed to compare whether invitation to screening with faecal immunochemical test was non-inferior to colonoscopy in a screening programme. Methods: COLONPREV was a pragmatic, randomised, controlled, non-inferiority trial done at 15 tertiary hospitals across eight regions of Spain. Eligible participants were presumptively healthy and aged between 50 years and 69 years without a personal history of colorectal cancer, adenoma or inflammatory bowel disease, family history of hereditary or familial colorectal cancer (ie, two or more first-degree relatives with colorectal cancer or one diagnosed before age 60 years), severe comorbidities, or previous colectomy. Participants were randomly assigned (1:1) to one-time colonoscopy or biennial faecal immunochemical test before invitation to screening. The primary endpoint was colorectal cancer mortality at 10 years, assessed in the intention-to-screen population. An absolute difference of less than 0·16 percentage points was required to show non-inferiority. This trial was registered with ClinicalTrials.gov, NCT00906997. Findings: Between June 1, 2009, and Dec 31, 2021, 57 404 individuals were randomly assigned to receive an invitation for colonoscopy (n=28 708) or the faecal immunochemical test (n=28 696). The intention-to-screen population consisted of 26 332 individuals in the colonoscopy group and 26 719 in the faecal immunochemical test group. In the intention-to-screen population, participation in any form of screening was 31·8% in the colonoscopy group and 39·9% in the faecal immunochemical test group (risk ratio [RR] 0·79 [95% CI 0·77 to 0·82]). Faecal immunochemical testing was non-inferior to colonoscopy with regard to the risk of colorectal cancer mortality at 10 years: the risk was 0·22% (55 deaths) in the colonoscopy group and 0·24% (60 deaths) in the faecal immunochemical test group (risk difference -0·02 [95% CI -0·10 to 0·06; RR 0·92 [95% CI 0·64 to 1·32]; pnon-inferiority=0·0005). Interpretation: Participation in screening was higher among individuals invited to faecal immunochemical test screening than colonoscopy screening. On the basis of participation observed in this study, a faecal immunochemical test-based programme was non-inferior to a colonoscopy-based programme for colorectal cancer-related mortality.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Sex‐ and Age‐Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post‐Analysis of the COLONPREV Study

  • Castells, Antoni
  • Quintero, Enrique
  • Serra-Burriel, Miquel
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Cubiella, Joaquín
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Ono, Akiko
  • Coll-Vinent, Blanca
  • Frías-Arrocha, Eladio
  • Hernández, Cristina
  • Jover, Rodrigo
  • Andreu, Montserrat
  • Carballo, Fernando
  • Morillas, Juan Diego
  • Salas, Dolores
Background. Colorectal cancer (CRC) screening is effective and cost-effective in average-risk individuals. The COLONPREV study recently showed that individuals invited to a faecal immunochemical test (FIT) were more likely to participate in screening than those invited to colonoscopy, and that FIT-based screening was non-inferior to colonoscopy with respect to CRC-related mortality and CRC incidence. Objective. To assess whether the outcomes of colonoscopy- and FIT-based screening differ according to sex and age in the invited population. Methods. Presumptively healthy men and women aged 50–69 years were randomised to either a one-time screening colonoscopy or biennial FIT. In this analysis, we report participation and crossover rates, CRC-related mortality, CRC incidence, all-cause mortality, and diagnostic yield for both screening strategies, stratified by sex and by age group (50–59 and 60–69 years). Results. The eligible population consisted of 26,332 individuals assigned to colonoscopy and 26,719 assigned to FIT. As expected, participation and crossover rates were higher in women than in men and in older individuals compared with younger individuals. Participation was also consistently higher in those invited to FIT screening than in those assigned to colonoscopy across both sexes and age groups. The observed reductions in CRC-related mortality and CRC incidence, which were consistent across both screening strategies, were independent of sex or age. However, CRC-related mortality, all-cause mortality, and CRC incidence remained higher in men and older participants than in women and younger participants. Colonoscopy screening showed a higher diagnostic yield of premalignant precursor lesions across all demographic subgroups. Conclusion. Participation and reductions in CRC-related mortality and incidence were consistent across sex and age groups for both FIT- and colonoscopy-based screening strategies. The higher baseline risk observed in men could not be fully mitigated by screening. Trial Registration. ClinicalTrials.gov: NCT00906997
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Association between dietary patterns and cardiometabolic health in children: findings from the Childhood Obesity Risk Assessment Longitudinal Study (CORALS) cohort

  • Gheorghita, Irina
  • Gispert-Llauradó, Mariona
  • Escribano, Joaquin
  • Jurado-Castro, Jose Manuel
  • Babio, Nancy
  • Leis, Rosaura
  • Moreno, Luis A.
  • Navas-Carretero, Santiago
  • Corella, Dolores
  • Moreira, Ana
  • Castro-Collado, Cristina
  • Vázquez-Cobela, Rocío
  • Alcázar, Mireia
  • Miguel-Berges, María L.
  • Martinez, J. Alfredo
  • Pastor-Villaescusa, Belén
  • Picáns-Leis, Rosaura
  • Mimbrero, Gisela
  • De Miguel-Etayo, Pilar
  • Flores-Rojas, Katherine
  • Gil-Campos, Mercedes
  • Salas-Salvadó, Jordi
  • Luque, Veronica
  • Schröder, Helmut
  • Fitó, Montse
  • Pérez-Vega, Karla A.
  • Solis Baltodano, Mayela
  • Muñoz-Aguayo, Daniel
  • Blanchart, Gemma
  • Gaixas, Sònia
  • Zomeño, María Dolores
  • Lorenzo, Isaury
  • Gil-Campos, Mercedes
  • Jurado-Castro, José Manuel
  • Pastor-Villaescusa, Belén
  • Llorente-Cantarero, Francisco Jesús
  • De La Torre-Aguilar, María José
  • Velasco Aguayo, Inmaculada
  • Navas-Carretero, Santiago
  • Martínez, J. Alfredo
  • Moreno-Aliaga, Maria Jesús
  • de Cuevillas García, Begoña
  • Vázquez-Bolea, Natalia
  • Goñi, María
  • Hernández, María
  • Pérez Diez, Salomé
  • Cristobo, Carmen
  • Babio, Nancy
  • Salas-Salvadó, Jordi
  • Escribano, Joaquín
  • Luque, Veronica
  • Ferré, Natalia
  • Gheorghita, Irina
  • Feliu, Albert
  • Closa, Ricardo
  • Alcázar, Mireia
  • Martín, Francisco
  • Rey, Cristina
  • Mimbrero, Gisela
  • Pedraza, Ana
  • Salvadó, Olga
  • Ruiz Velasco, Marta
  • Bilbao Sustacha, José Ángel
  • Herranz Pinilla, Yolanda
  • Rios, Lidia
  • Pascual Compte, María
  • Garcidueñas-Fimbres, Tany E.
  • Gómez-Martínez, Carlos
  • de las Heras-Delgado, Sara
  • Simón, Olga
  • de la Torre, Sònia
  • Tudela, Càrol
  • Valero Sales, Júlia
  • Moroño García, Sara
  • Leis, Rosaura
  • Romero Agrelo, Anabel
  • Picáns-Leis, Rosaura
  • García-García, Eva
  • Mosteiro-Losada, Sofia
  • Portoles, Olga
  • Codoñer Franch, Pilar
  • Corella, Dolores
  • Martín Carbonell, Vanessa
  • Sorlí, José V.
  • Moreno, Luis A.
  • De Miguel-Etayo, Pilar
  • Miguel-Berges, María Luisa
  • Santaliestra-Pasias, Alba Mª
  • Argente-Arizon, Pilar
  • Gimenez-Legarre, Natalia
  • Flores-Barrantes, Paloma
  • Pérez-Gimeno, Gloria
  • Seral-Cortés, Miguel
  • Jimeno-Martínez, Andrea
  • Maneschy, Ivie
  • Benedicto, Isabel
Background: Dietary habits influence health from childhood, with effects that may persist throughout life. This study aimed to investigate the association between dietary patterns and cardiometabolic risk markers in early childhood. Methods: A cross-sectional analysis was performed within the Childhood Obesity Risk Assessment Longitudinal Study (CORALS) cohort. Diet was assessed by a validated food frequency questionnaire. Dietary patterns were extracted using exploratory factor analysis. Cardiometabolic risk was analysed through internal z-scores, body mass index (BMIz), systolic blood pressure, HDL cholesterol (HDLz), triglycerides and HOMA-IR, and multi-adjusted linear regression models were performed. Results: The analysis included 1426 participants (median age 4.95 years). Two dietary patterns (DPs) were identified: “Core-foods DP” (high in vegetables, fruits, nuts, legumes, fish and white meat) and “Poor-quality DP” (rich in flavoured dairy products, processed meat, pastries, sweets, snacks, precooked foods, other oils and soft drinks). Core-foods DP was inversely associated with BMIz (B = -0.07, p = 0.034), meanwhile the Poor-quality DP was directly associated with triglycerides (B = 0.09, p = 0.015) and higher overweight odds (OR:1.33; 95% CI:1.13–1.56), and inversely with HDLz (B = −0.08, p = 0.036). Conclusion: Poor-quality DP was directly associated with cardiometabolic risk markers in preschool-aged children, emphasizing the importance of diet in preventing the early onset of obesity and cardiometabolic disorders. Impact: This study highlights the impact of dietary patterns on cardiometabolic health in preschool children. A poor-quality dietary pattern is directly associated with BMI and triglycerides and inversely associated with HDL cholesterol, which may contribute to a worse cardiometabolic profile. In contrast, adherence to a core-foods pattern is inversely associated with BMI. These findings reinforce the importance of early nutrition education in preventing obesity and cardiometabolic disorders. This article provides evidence of diet-related metabolic risks in early life to limited existing literature and the need for interventions that promote healthier eating habits from an early age to improve long-term health outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Long‐Term Colorectal Cancer Incidence After Adenoma and Serrated Polyp Removal: Results From the Colonprev Trial

  • Cubiella, Joaquín
  • García-Benito, Carme
  • Castells, Antoni
  • Quintero, Enrique
  • Bujanda, Luis
  • Castán-Cameo, Susana
  • Díaz-Tasende, José
  • Lanas, Ángel
  • Ono, Akiko
  • Frías-Arrocha, Eladio
  • Hernández, Cristina
  • Jover, Rodrigo
  • Andreu, Montserrat
  • Carballo, Fernando
  • Morillas, Juan Diego
  • Salas, Dolores
  • Regueiro-Expósito, Cristina
  • Davila-Piñón, Pedro
  • Diez-Martín, Astrid
Background: The risk of colorectal cancer (CRC) after serrated polyp resection remains unclear, and current surveillance recommendations rely on limited evidence. We evaluated CRC incidence in individuals with advanced serrated lesions (ASL) detected at baseline colonoscopy and compared risk according to the most advanced lesion identified. Methods: Participants undergoing colonoscopy within the COLONPREV trial (n = 8989) were included in this post hoc analysis. Individuals were classified according to the most advanced baseline lesion: no lesion, non-advanced adenoma, advanced adenoma, or ASL. The primary outcome was incident CRC. Cumulative incidence and hazard ratios (HR) were estimated using Cox proportional hazard models. Results: At baseline colonoscopy, serrated polyps were detected in 19.8% of participants, including ASL in 2.5%. Over a mean follow-up of 9.5 years, 44 CRC cases were diagnosed (cumulative incidence 0.49%; incidence rate 0.52 per 1000 person-years). The 10-year cumulative incidence was 0.27% in individuals without baseline lesions (n = 5496), 0.57% in those with non-advanced adenomas (n = 2091), 1.23% in advanced adenomas (n = 1218), and 1.09% in ASL (n = 184). In multivariable analysis, CRC risk was increased for non-advanced adenomas (HR 3.25, 95% CI 1.48–7.16), advanced adenomas (HR 9.77, 95% CI 4.24–22.50), and ASL (HR 6.37, 95% CI 1.42–28.54). Surveillance colonoscopy was associated with lower CRC incidence (HR 0.46, 95% CI 0.22–0.95 for one colonoscopy; HR 0.09, 95% CI 0.02–0.40 for ≥ 2 colonoscopies). Conclusion: In this screening cohort, ASL were associated with increased CRC risk in the range of advanced adenomas. These findings provide risk estimates relevant to post-polypectomy management.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Metabolomic profiling of ultra-processed food consumption and cardiovascular risk in Spanish preschool children: a cross-sectional study

  • Pérez-Acosta, Josué A.
  • García-Gavilán, Jesús F.
  • Margara-Escudero, Hernando J.
  • Aguilera, Concepción M.
  • Leis, Rosaura
  • Gheorghita, Irina
  • Miguel-Berges, María L.
  • Navas-Carretero, Santiago
  • Sorlí, José V.
  • Lázaro, Iolanda
  • Pastor-Villaescusa, Belén
  • Vázquez-Cobela, Rocío
  • Iglesias-Vázquez, Lucía
  • De Miguel-Etayo, Pilar
  • Vazquez-Bolea, Natalia
  • Jurado-Castro, José Manuel
  • Picáns-Leis, Rosaura
  • Escribano, Joaquín
  • Moreno, Luis A.
  • Torre-Aguilar, MJosé de la
  • Gil-Campos, Mercedes
  • Salas-Salvadó, Jordi
  • Babio, Nancy
Background Ultra-processed food (UPF) consumption has increased substantially among children worldwide and has been associated with early cardiovascular alterations. We aimed to identify plasma metabolomic profiles associated with UPF consumption in children aged 3–6 years and to assess their association with cardiovascular risk factors. Methods This cross-sectional analysis used baseline data from the Childhood Obesity Risk Assessment Longitudinal Study (CORALS), with children recruited between March 2019 and June 2022 through primary schools and health-care centres in seven Spanish cities. 1148 children were included (mean age 5.0 years [SD 1.1]; 50.6% girls) after exclusions due to medical conditions and incomplete or implausible dietary or metabolomic data. Energy-adjusted UPF intake (g/d) was assessed using a validated food frequency questionnaire and categorised with NOVA classification. 249 metabolites were quantified by NMR-based metabolomics, and lipid-related and amino acid-related profiles/scores were derived. A composite cardiovascular risk score (CVRs) was constructed by summing sex-specific, age-adjusted z-scores for fat-mass index, HDL-and LDL-cholesterol, triglycerides, mean arterial pressure, and Homoeostatic Model Assessment for Insulin Resistance. Findings 19 metabolites were associated with UPF consumption after false discovery rate correction (FDR). A lipid-related score was positively associated with CVRs (β = 0.511; 95% CI: 0.413–0.610; FDR <0.001) and the amino acid–related score was associated with a lower CVRs (β = −0.494; 95% CI: −0.667 to −0.321; FDR <0.001). Discrimination of cardiovascular risk beyond covariates alone was higher after inclusion of metabolomic scores, particularly when both scores were considered jointly (ΔAUC 0.092, 95% CI: 0.013–0.172; p = 0.020). Interpretation In Spanish pre-schoolers UPF-related metabolomic profiles were associated with different cardiovascular risk factors. These diet-related metabolomic scores capture biological correlates relevant to early cardiovascular health and align with early-life metabolic pattering, supporting future longitudinal studies and prevention strategies.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients

  • JOUVE, Thomas
  • Bin, Sofia
  • Hartzell, Susan
  • Torija Recasens, Alba
  • Jarque, Marta
  • KERVELLA, Delphine
  • Zuñiga-Vergara, Jose-Miguel
  • Font-Miñarro, Cristina
  • Torres Rodriguez, Irina Betsabe
  • Sellarés Roig, Joana
  • Perelló, Manel
  • Donadeu Casassas, Laura
  • Martínez Gallo, Mónica
  • Meneghini, Maria
  • TOAPANTA, NÉSTOR
  • Moreso, Francesc
  • Bestard, Oriol
  • Crespo, Elena
Cytomegalovirus; Kidney transplantation; Mass spectrometry, Citomegalovirus; Trasplante de riñón; Espectrometría de masas, Citomegalovirus; Trasplantament de ronyó; Espectrometria de masses, Cytomegalovirus (CMV) infection is associated with poor kidney transplant outcomes. While innate and adaptive immune cells have been implicated in its prevention, an in-depth characterization of the in vivo kinetics of multiple cell subsets and their role in protecting against CMV infection has not been achieved. Here, we performed high-dimensional immune phenotyping by mass cytometry, and functional assays, on 112 serially collected samples from CMV seropositive kidney transplant recipients. Advanced unsupervised deep learning analysis was used to assess immune cell populations that significantly correlated with prevention against CMV infection and anti-viral immune function. Prior to infection, kidney transplant recipients who developed CMV infection showed significantly lower CMV-specific cell-mediated immune (CMI) frequencies than those that did not. A broad diversity of circulating cell subsets within innate and adaptive immune compartments were associated with CMV infection or protective CMV-specific CMI. While percentages of CMV (tetramer-stained)-specific T cells associated with high CMI responses and clinical protection, circulating CD3+CD8midCD56+ NK-T cells overall strongly associated with low CMI and subsequent infection. However, three NK-T cell subsets sharing the CD11b surface marker associated with CMV protection and correlated with strong anti-viral CMI frequencies in vitro. These data were validated in two external independent cohorts of kidney transplant recipients. Thus, we newly describe the kinetics of a novel NK-T cell subset that may have a protective role in post-transplantation CMV infection. Our findings pave the way to more mechanistic studies aimed at understanding the function of these cells in protection against CMV infection., LD received a research fellowship grant from the “Instituto de Salud Carlos III” (FI22/00252). TJ received a fellowship grant from the European Society of Organ Transplantation (2020 fellowship grant). PC is acting as a consultant for Chinook Therapeutics and has received research funding from Chinook Therapeutics. OB’s research activity is partly supported by Instituto de Salud Carlos III (grant numbers PI19/01710 and PI22/01019; cofunded by the European Regional Development Fund, a way to build Europe) and redes de Investigación Cooperativa Orientadas a Resultados en Salud consortia by the Instituto de Salud Carlos III. Also, the work was partially funded by a European Union Horizon 2020 research and innovation program under grant agreement 754995 (EUTRAIN).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation

  • Casanova, Franc
  • Kotton, Camille
  • Donadeu Casassas, Laura
  • Kumar, Deepali
  • Pineda SanJuan, Silvia
  • Martínez Lacalle, Anna
  • Castañeda Amado, Zaira Ivette
  • KERVELLA, Delphine
  • Crespo, Elena
  • Meneghini, Maria
  • Torres, Irina B.
  • Martínez Gallo, Mónica
  • Len, Oscar
  • Los-Arcos, Ibai
  • Enrique, Trilla Herrera
  • Miret Alomar, Enric
  • Moreso, Francesc
  • Bestard, Oriol
Breastfeeding; Breast cancer, Lactancia materna; Cáncer de mama, Lactància materna; Càncer de mama, Background: We investigated safety of breastfeeding after breast cancer in patients carrying germline BRCA pathogenic or likely pathogenic variants. Methods: This was an international, multicentre, hospital-based, retrospective cohort study including BRCA carriers diagnosed with stage I-III invasive breast cancer at age 40 years or younger between January 2000 and December 2020 (NCT03673306). Locoregional recurrences and/or contralateral breast cancers, disease-free survival (DFS) and overall survival (OS) were compared between patients who breastfed after delivery and those who did not. Results: Among 4732 patients included from 78 centres worldwide, 659 had a pregnancy after breast cancer diagnosis, of whom 474 delivered a child. After excluding patients with uptake of bilateral risk-reducing mastectomy prior to delivery (n = 225) or unknown breastfeeding status (n = 71), 110 (61.8%) breastfed (median duration 5 months) and 68 (38.2%) did not breastfeed. Compared to patients in the no breastfeeding group, those who breastfed were more frequently nulliparous at breast cancer diagnosis (61.8% vs 45.6%) and did not report prior smoking habit (71.8% vs 57.4%).After a median follow up of 7.0 years following delivery, 7-year cumulative incidence of locoregional recurrences and/or contralateral breast cancers was 29% in the breastfeeding group and 37% in the no breastfeeding group (adjusted subdistribution hazard ratio[HR]=1.08, 95%CI 0.57-2.06). No difference in DFS (aHR = 0.83, 95%CI 0.49-1.41) nor in OS (aHR = 1.32, 95%CI 0.31-5.66) was observed. Conclusions: Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers, emphasizing the possibility of achieving a balance between maternal and infant needs without compromising oncological safety., LD received a research fellowship grant from the “Instituto de Salud Carlos III” [FI22/00252]. OB’s research activity is partly supported by Instituto de Salud Carlos III (ISCII) (grant numbers PI19/01710 and PI22/01019) (Cofunded by European Regional Development Fund, ERDF-ESF, a way to build Europe) and RICORS (redes de Investigación Cooperativa Orientadas a Resultados en Salud) consortia by the Instituto de Salud Carlos III. In addition, the work was partially funded by a European Union’s Horizon 2020 research and innovation program under grant agreement No 754995 (EUTRAIN). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding institutions.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice

  • Martos Guillamé, Nerea
  • MOTTO, Aku Enam
  • Gonçalves, Francisco
  • Garcias Ramis, Maria Magdalena
  • Allo-Urzainqui, Estibaliz
  • NARVAEZ BARROS, ALONSO
  • Muñoz Vañó, Vicent
  • León-Román, Juan
  • Vilardell-Vilà, Jordi
  • Vergara, Ander
  • Llorens Cebrià, Carmen
  • Martínez Díaz, Irene
  • Bermejo García, Sheila
  • Ferrer Costa, Roser
  • Jacobs-Cacha, Conxita
  • Soler, María José
Chronic kidney disease; Diabetic kidney disease; Sodium-glucose cotransporter 2 inhibitors, Enfermedad renal crónica; Enfermedad renal diabética; Inhibidores del cotransportador sodio-glucosa 2, Malaltia renal crònica; Malaltia renal diabètica; Inhibidors del cotransportador sodi-glucosa 2, Introduction: Diabetic Kidney Disease (DKD) is the main cause of end-stage renal disease in the developed world. The current treatment of the DKD with renin-angiotensin system (RAS) blockade does not totally halt the progression to end stage kidney disease. Currently, several drugs have shown to delay DKD progression such as sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like-1 receptor agonists (GLP-1RA). We hypothesized that by combining several drugs that prevent DKD progression on top of RAS blockade a synergistic effect would be achieved in terms of cardiorenal protection. In the present study, we analysed if the combination of a RAS blocker (ramipril) with a SGLT2i (empagliflozin) and/or GLP-1RA (semaglutide) in a type 2 diabetic mouse model could have add-on effects in kidney and heart protection. Methods: Male and female uninephrectomized type 2 diabetic db/db mice were treated with empagliflozin and/or semaglutide on top of ramipril during 8 weeks. During the study body weight, water and food intake were weekly monitored, glycaemia biweekly and albuminuria and glomerular filtration rate (GFR) before and after the treatment. At the end of the experiment, kidney and heart were isolated for histological and gene expression studies as well as for intrarenal RAS state assessment. Results: Semaglutide combined with ramipril and/or empagliflozin significantly decreased albuminuria but only when combined with both compounds, semaglutide further decreased blood glucose, glomerular hyperfiltration in male mice and glomerular mesangial matrix expansion. In kidney, only the triple treatment with empagliflozin, semaglutide and ramipril reduced the expression of the proinflammatory and profibrotic genes ccl2 and TGFß1. In addition, the combination of empagliflozin and semaglutide on top of RAS blockade was superior in decreasing cardiomyocyte hypertrophy and heart fibrosis in db/db mice. Discussion: Our results suggest that the combination of SGLT2i with GLP-1RA is superior in cardiorenal protection in DKD than the drugs administered alone on top of RAS blockade., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The study was funded with a grant from Instituto de Salud Carlos III (PI21/01292). JL-R received a Rio Hortega grant from the Instituto de Salud Carlos III (CM23/00213), and IM received a PFIS grant from the Instituto de Salud Carlos III (FI22/00335). The authors are also recipients of other research grants from Instituto de Salud Carlos III (AC22/00029) and the Fundació la Marató de TV3 (202017-10, 202037-31, and 202133-30). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883). The Clinical Biochemistry, Drug Delivery and Therapy Research Group is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 01173).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Apelinergic System in Kidney Disease: Novel Perspectives

  • Saladich-Cavallé, Sara
  • Huo, Linhui
  • Pons Pellicer, Frederic
  • Vilardell-Vilà, Jordi
  • Núñez Delgado, Sara
  • Martínez Díaz, Irene
  • Jacobs-Cacha, Conxita
  • Bermejo García, Sheila
  • Soler, María José
Chronic kidney disease in persons with diabetes; Apelin; Chronic kidney disease, Enfermedad renal crónica en personas con diabetes; Apelin; Enfermedad renal crónica, Malaltia renal crònica en persones amb diabetis; Apelin; Malaltia renal crònica, Chronic kidney disease (CKD) is a major complication of diabetes, affecting approximately 30–40% of patients. In many cases, CKD progresses to end-stage renal disease (ESRD). The peptide apelin and its receptor, APLNR, which is expressed in the endothelial cells of renal blood vessels, play a key role in glucose uptake and the regulation of vasodilation in the afferent and efferent glomerular arterioles. Numerous studies have demonstrated that the apelinergic system is dysregulated in various pathologies, including CKD in people with diabetes. In recent years, the apelinergic system has emerged as a promising therapeutic target for several diseases, with various apelin analogs and inhibitors being developed. In this review, we summarize the most recent literature on apelin and its cellular mechanisms of action, highlighting the role of the apelinergic system in various pathologies and its impact on patients with CKD and diabetes. Additionally, we explore the currently available analogs and inhibitors and discuss their potential therapeutic applications., This study was funded by a research grant from Boehringer Ingelheim. I.M.-D was awarded a PFIS grant from the Instituto de Salud Carlos III (FI22/00335), and L.H. was awarded a China Scholarship Council (CSC) grant. The authors are also recipients of other research grants from Instituto de Salud Carlos III (PI21/01292, AC22/00029, INT23/00078, PI24/01573, PI24/01510). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/31 and RD24/0004/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883). The Clinical Biochemistry, Drug Delivery, and Therapy Research Group is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 01173).
Docta Complutense
Publication Artículo científico (JournalArticle)

Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

  • Díaz Navarro, Marta
  • Hafian, Rama
  • Pérez Granda, María Jesús
  • Cercenado Mansilla, Emilia
  • Muñoz García, Patricia Carmen
  • Guembe, María
Introduction: The possible use of dalbavancin as a catheter lock solution was previously demonstrated by our study group. However, it was needed to assess whether heparin could affect dalbavancin bioactivity during freezing storage. Methods: We tested the bioactivity of a dalbavancin+heparin (DH) vs. dalbavancin (D) against Staphylococcal biofilms comparing DH median value of cfu counts and metabolic activity with that obtained for D before and during storage under freezing up to 6 months. Results: Despite there was a slight decrease in the median percentage reduction of metabolic activity at month 3 in Staphylococcus epidermidis between DH and D (97.6 vs. 100, p=0.037), considering the clinical criteria, no significant reduction in any of the variables tested was observed at the end of the experiment between D and DH solutions. Conclusion: The addition of heparin to a dalbavancin lock solution did not affect its bioactivity against staphylococcal biofilms irrespective of its preservation time under freezing. Keywords: Bioactividad; Bioactivity; Biofilms; Biopelículas; Congelación; Dalbavancin; Dalbavancina; Freezing; Heparin; Heparina; Lock therapy; Terapia de sellado.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome

  • Aranha, Mateus|||0000-0001-9594-292X
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Montal, Victor|||0000-0002-5714-9282
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Grothe, Michel|||0000-0003-2600-9022
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Benejam, Bessy|||0000-0002-6789-8615
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Padilla, Concepción|||0000-0003-4102-6787
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Fernández, Susana|||0000-0002-9777-1156
  • Ribas, Laia
  • Valle-Tamayo, Natalia|||0000-0001-9322-3710
  • Alcolea, Daniel|||0000-0002-3819-3245
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Bargalló, Núria|||0000-0001-6284-5402
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Blennow, Kaj|||0000-0002-1890-4193
  • Blesa, Rafael|||0000-0003-4026-2884
  • Wisniewski, Thomas M.
  • Busciglio, Jorge A.
  • Cuello, AC.|||0000-0003-2143-2745
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
Background: Basal forebrain (BF) degeneration occurs in Down syndrome (DS)-associated Alzheimer's disease (AD). However, the dynamics of BF atrophy with age and disease progression, its impact on cognition, and its relationship with AD biomarkers have not been studied in DS. Methods: We included 234 adults with DS (150 asymptomatic, 38 prodromal AD, and 46 AD dementia) and 147 euploid controls. BF volumes were extracted from T-weighted magnetic resonance images using a stereotactic atlas in SPM12. We assessed BF volume changes with age and along the clinical AD continuum and their relationship to cognitive performance, cerebrospinal fluid (CSF) and plasma amyloid/tau/neurodegeneration biomarkers, and hippocampal volume. Results: In DS, BF volumes decreased with age and along the clinical AD continuum and significantly correlated with amyloid, tau, and neurofilament light chain changes in CSF and plasma, hippocampal volume, and cognitive performance. Discussion: BF atrophy is a potentially valuable neuroimaging biomarker of AD-related cholinergic neurodegeneration in DS.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

A New Prognostic Score Based on Cell-Mediated Immunity for Cytomegalovirus Infection After Transplantation

  • Casanova, Franc
  • Kotton, Camille
  • Donadeu Casassas, Laura
  • Kumar, Deepali
  • Pineda SanJuan, Silvia
  • Martínez Lacalle, Anna
  • Castañeda Amado, Zaira Ivette
  • KERVELLA, Delphine
  • Crespo, Elena
  • Meneghini, Maria
  • Torres, Irina B.
  • Martínez Gallo, Mónica
  • Len, Oscar
  • Los-Arcos, Ibai
  • Enrique, Trilla Herrera
  • Miret Alomar, Enric
  • Moreso, Francesc
  • Bestard, Oriol
Breastfeeding; Breast cancer, Lactancia materna; Cáncer de mama, Lactància materna; Càncer de mama, Background: We investigated safety of breastfeeding after breast cancer in patients carrying germline BRCA pathogenic or likely pathogenic variants. Methods: This was an international, multicentre, hospital-based, retrospective cohort study including BRCA carriers diagnosed with stage I-III invasive breast cancer at age 40 years or younger between January 2000 and December 2020 (NCT03673306). Locoregional recurrences and/or contralateral breast cancers, disease-free survival (DFS) and overall survival (OS) were compared between patients who breastfed after delivery and those who did not. Results: Among 4732 patients included from 78 centres worldwide, 659 had a pregnancy after breast cancer diagnosis, of whom 474 delivered a child. After excluding patients with uptake of bilateral risk-reducing mastectomy prior to delivery (n = 225) or unknown breastfeeding status (n = 71), 110 (61.8%) breastfed (median duration 5 months) and 68 (38.2%) did not breastfeed. Compared to patients in the no breastfeeding group, those who breastfed were more frequently nulliparous at breast cancer diagnosis (61.8% vs 45.6%) and did not report prior smoking habit (71.8% vs 57.4%).After a median follow up of 7.0 years following delivery, 7-year cumulative incidence of locoregional recurrences and/or contralateral breast cancers was 29% in the breastfeeding group and 37% in the no breastfeeding group (adjusted subdistribution hazard ratio[HR]=1.08, 95%CI 0.57-2.06). No difference in DFS (aHR = 0.83, 95%CI 0.49-1.41) nor in OS (aHR = 1.32, 95%CI 0.31-5.66) was observed. Conclusions: Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers, emphasizing the possibility of achieving a balance between maternal and infant needs without compromising oncological safety., LD received a research fellowship grant from the “Instituto de Salud Carlos III” [FI22/00252]. OB’s research activity is partly supported by Instituto de Salud Carlos III (ISCII) (grant numbers PI19/01710 and PI22/01019) (Cofunded by European Regional Development Fund, ERDF-ESF, a way to build Europe) and RICORS (redes de Investigación Cooperativa Orientadas a Resultados en Salud) consortia by the Instituto de Salud Carlos III. In addition, the work was partially funded by a European Union’s Horizon 2020 research and innovation program under grant agreement No 754995 (EUTRAIN). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding institutions.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

The Apelinergic System in Kidney Disease: Novel Perspectives

  • Saladich-Cavallé, Sara
  • Huo, Linhui
  • Pons Pellicer, Frederic
  • Vilardell-Vilà, Jordi
  • Núñez Delgado, Sara
  • Martínez Díaz, Irene
  • Jacobs-Cacha, Conxita
  • Bermejo García, Sheila
  • Soler, María José
Chronic kidney disease in persons with diabetes; Apelin; Chronic kidney disease, Enfermedad renal crónica en personas con diabetes; Apelin; Enfermedad renal crónica, Malaltia renal crònica en persones amb diabetis; Apelin; Malaltia renal crònica, Chronic kidney disease (CKD) is a major complication of diabetes, affecting approximately 30–40% of patients. In many cases, CKD progresses to end-stage renal disease (ESRD). The peptide apelin and its receptor, APLNR, which is expressed in the endothelial cells of renal blood vessels, play a key role in glucose uptake and the regulation of vasodilation in the afferent and efferent glomerular arterioles. Numerous studies have demonstrated that the apelinergic system is dysregulated in various pathologies, including CKD in people with diabetes. In recent years, the apelinergic system has emerged as a promising therapeutic target for several diseases, with various apelin analogs and inhibitors being developed. In this review, we summarize the most recent literature on apelin and its cellular mechanisms of action, highlighting the role of the apelinergic system in various pathologies and its impact on patients with CKD and diabetes. Additionally, we explore the currently available analogs and inhibitors and discuss their potential therapeutic applications., This study was funded by a research grant from Boehringer Ingelheim. I.M.-D was awarded a PFIS grant from the Instituto de Salud Carlos III (FI22/00335), and L.H. was awarded a China Scholarship Council (CSC) grant. The authors are also recipients of other research grants from Instituto de Salud Carlos III (PI21/01292, AC22/00029, INT23/00078, PI24/01573, PI24/01510). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/31 and RD24/0004/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883). The Clinical Biochemistry, Drug Delivery, and Therapy Research Group is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 01173).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients

  • JOUVE, Thomas
  • Bin, Sofia
  • Hartzell, Susan
  • Torija Recasens, Alba
  • Jarque, Marta
  • KERVELLA, Delphine
  • Zuñiga-Vergara, Jose-Miguel
  • Font-Miñarro, Cristina
  • Torres Rodriguez, Irina Betsabe
  • Sellarés Roig, Joana
  • Perelló, Manel
  • Donadeu Casassas, Laura
  • Martínez Gallo, Mónica
  • Meneghini, Maria
  • TOAPANTA, NÉSTOR
  • Moreso, Francesc
  • Bestard, Oriol
  • Crespo, Elena
Cytomegalovirus; Kidney transplantation; Mass spectrometry, Citomegalovirus; Trasplante de riñón; Espectrometría de masas, Citomegalovirus; Trasplantament de ronyó; Espectrometria de masses, Cytomegalovirus (CMV) infection is associated with poor kidney transplant outcomes. While innate and adaptive immune cells have been implicated in its prevention, an in-depth characterization of the in vivo kinetics of multiple cell subsets and their role in protecting against CMV infection has not been achieved. Here, we performed high-dimensional immune phenotyping by mass cytometry, and functional assays, on 112 serially collected samples from CMV seropositive kidney transplant recipients. Advanced unsupervised deep learning analysis was used to assess immune cell populations that significantly correlated with prevention against CMV infection and anti-viral immune function. Prior to infection, kidney transplant recipients who developed CMV infection showed significantly lower CMV-specific cell-mediated immune (CMI) frequencies than those that did not. A broad diversity of circulating cell subsets within innate and adaptive immune compartments were associated with CMV infection or protective CMV-specific CMI. While percentages of CMV (tetramer-stained)-specific T cells associated with high CMI responses and clinical protection, circulating CD3+CD8midCD56+ NK-T cells overall strongly associated with low CMI and subsequent infection. However, three NK-T cell subsets sharing the CD11b surface marker associated with CMV protection and correlated with strong anti-viral CMI frequencies in vitro. These data were validated in two external independent cohorts of kidney transplant recipients. Thus, we newly describe the kinetics of a novel NK-T cell subset that may have a protective role in post-transplantation CMV infection. Our findings pave the way to more mechanistic studies aimed at understanding the function of these cells in protection against CMV infection., LD received a research fellowship grant from the “Instituto de Salud Carlos III” (FI22/00252). TJ received a fellowship grant from the European Society of Organ Transplantation (2020 fellowship grant). PC is acting as a consultant for Chinook Therapeutics and has received research funding from Chinook Therapeutics. OB’s research activity is partly supported by Instituto de Salud Carlos III (grant numbers PI19/01710 and PI22/01019; cofunded by the European Regional Development Fund, a way to build Europe) and redes de Investigación Cooperativa Orientadas a Resultados en Salud consortia by the Instituto de Salud Carlos III. Also, the work was partially funded by a European Union Horizon 2020 research and innovation program under grant agreement 754995 (EUTRAIN).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice

  • Martos Guillamé, Nerea
  • MOTTO, Aku Enam
  • Gonçalves, Francisco
  • Garcias Ramis, Maria Magdalena
  • Allo-Urzainqui, Estibaliz
  • NARVAEZ BARROS, ALONSO
  • Muñoz Vañó, Vicent
  • León-Román, Juan
  • Vilardell-Vilà, Jordi
  • Vergara, Ander
  • Llorens Cebrià, Carmen
  • Martínez Díaz, Irene
  • Bermejo García, Sheila
  • Ferrer Costa, Roser
  • Jacobs-Cacha, Conxita
  • Soler, María José
Chronic kidney disease; Diabetic kidney disease; Sodium-glucose cotransporter 2 inhibitors, Enfermedad renal crónica; Enfermedad renal diabética; Inhibidores del cotransportador sodio-glucosa 2, Malaltia renal crònica; Malaltia renal diabètica; Inhibidors del cotransportador sodi-glucosa 2, Introduction: Diabetic Kidney Disease (DKD) is the main cause of end-stage renal disease in the developed world. The current treatment of the DKD with renin-angiotensin system (RAS) blockade does not totally halt the progression to end stage kidney disease. Currently, several drugs have shown to delay DKD progression such as sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like-1 receptor agonists (GLP-1RA). We hypothesized that by combining several drugs that prevent DKD progression on top of RAS blockade a synergistic effect would be achieved in terms of cardiorenal protection. In the present study, we analysed if the combination of a RAS blocker (ramipril) with a SGLT2i (empagliflozin) and/or GLP-1RA (semaglutide) in a type 2 diabetic mouse model could have add-on effects in kidney and heart protection. Methods: Male and female uninephrectomized type 2 diabetic db/db mice were treated with empagliflozin and/or semaglutide on top of ramipril during 8 weeks. During the study body weight, water and food intake were weekly monitored, glycaemia biweekly and albuminuria and glomerular filtration rate (GFR) before and after the treatment. At the end of the experiment, kidney and heart were isolated for histological and gene expression studies as well as for intrarenal RAS state assessment. Results: Semaglutide combined with ramipril and/or empagliflozin significantly decreased albuminuria but only when combined with both compounds, semaglutide further decreased blood glucose, glomerular hyperfiltration in male mice and glomerular mesangial matrix expansion. In kidney, only the triple treatment with empagliflozin, semaglutide and ramipril reduced the expression of the proinflammatory and profibrotic genes ccl2 and TGFß1. In addition, the combination of empagliflozin and semaglutide on top of RAS blockade was superior in decreasing cardiomyocyte hypertrophy and heart fibrosis in db/db mice. Discussion: Our results suggest that the combination of SGLT2i with GLP-1RA is superior in cardiorenal protection in DKD than the drugs administered alone on top of RAS blockade., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The study was funded with a grant from Instituto de Salud Carlos III (PI21/01292). JL-R received a Rio Hortega grant from the Instituto de Salud Carlos III (CM23/00213), and IM received a PFIS grant from the Instituto de Salud Carlos III (FI22/00335). The authors are also recipients of other research grants from Instituto de Salud Carlos III (AC22/00029) and the Fundació la Marató de TV3 (202017-10, 202037-31, and 202133-30). The Nephrology and Transplantation group is part of the RICORS2040 network (RD21/0005/0031) and is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 00883). The Clinical Biochemistry, Drug Delivery and Therapy Research Group is recognized as a consolidated group by the Catalan Management Agency for University and Research Grants (2021 SGR 01173).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Effect of diactive-1 mHealth-supported progressive resistance training on insulin requirements, glycemic stability, and muscular strength in children and adolescents with type 1 diabetes: a parallel-group randomized controlled trial

  • Muñoz Pardeza, Jacinto
  • Hormazábal Aguayo, Ignacio
  • Huerta Uribe, Nidia
  • Chueca-Guindulain, María J.
  • Berrade-Zubiri, Sara
  • Martínez Vizcaíno, Vicente
  • Ezzatvar, Yasmin
  • López Gil, José Francisco
  • García Hermoso, Antonio
Datos de investigación alojados en: https://doi.org/10.2337/figshare.29599814, Objetive: to evaluate the effects of resistance training supported by the mobile health application Diactive-1 on the daily insulin dose and glycemic parameters in children and adolescents with type 1 diabetes. Rerearch design and methods: in this 24-week randomized clinical trial, Diactive-1 generated progressive overload resistance training sessions tailored to real-time glycemia and provided educational support. Insulin and glycemic parameters were collected from LibreView or CareLink, whereas glycosylated hemoglobin (HbA1c) was extracted from medical records. Muscular strength was assessed using a handgrip dynamometer and e-GYM machines, targeting pushing, pulling, and lower-limb movements. The effect was analyzed using linear mixed models. Results: sixty-two participants (age: 8–18 years, girls: 48%) with type 1 diabetes (HbA1c: 7.6% [60.4 mmol/mol]) were allocated to the usual care (n = 32) or the Diactive-1 group (n = 30). Daily insulin dose reductions were observed within the Diactive-1 group (mean difference [MD] −0.10 units/kg, 95% CI −0.18 to −0.01) and when compared with usual care (MD −0.17 units/kg, 95% CI −0.26 to −0.07). No adverse effects were observed on the glycemic risk index or the incidence of hypoglycemic events. Finally, handgrip strength (MD 2.90 kg, 95% CI 1.57–4.22), one-repetition maximum strength (MD 1.34, 95% CI 0.21–2.46), and muscular power (MD 0.97, 95% CI 0.01–1.93) increased. Four participants (6.5%) withdrew from the study. Conclusions: Diactive-1 appears to be a safe and feasible adjunct to standard care in children and adolescents with type 1 diabetes. Its resistance training component effectively reduced insulin requirements and improved muscular strength, without increasing the risk of adverse glycemic events., The study received financial support from Instituto de Salud Carlos III (Spain), funded by the European Union under grant number PI21/01238 and PI24/00829. In addition, Instituto de Salud Carlos III supported J.M.-P. with a competitive contract (FI22/00329).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Physical fitness and activity levels as predictors of subjective well-being in youths with type 1 diabetes mellitus: a 2-year longitudinal analysis of the diactive-1 cohort study

  • Muñoz Pardeza, Jacinto
  • López Gil, José Francisco
  • Huerta Uribe, Nidia
  • Hormazábal Aguayo, Ignacio
  • Yáñez-Sepúlveda, Rodrigo
  • Ezzatvar, Yasmin
  • Izquierdo Redín, Mikel
  • García Hermoso, Antonio
Subjective well-being (SWB), including cognitive and affective components, may be influenced by the management of type 1diabetes mellitus (T1DM). Physical fitness and adherence to physical activity (PA) are associated with better glycaemic stabilityand diabetes management. However, the relationship with SWB is not yet understood. The aim of the study was to determinethe relationship between physical fitness, PA, and SWB over two years in youths with T1DM. This longitudinal study involved83 participants (aged 6–18 years; 44.6% girls) from the Diactive-1 Cohort. Physical fitness was assessed by spirometry (peak ox-ygen consumption) and dynamometry (handgrip strength). PA domains were measured using triaxial accelerometers, whereasthe number of days participating in muscle-strengthening activities was assessed using a question. The Cuestionario Único deBienestar Escolar was used to determine SWB. Glycaemic stability was determined when glycosylated hemoglobin < 7%, coef-ficient of variability ≤ 36%, and time-in-range target > 70% were met. The linear mixed models used considered three assess-ments and subject variability, showing significant associations between overall physical fitness (unstandardized beta coefficient[B] = 1.778, 95% confidence interval [CI] 0.413–3.158; p = 0.012) and total PA (B = 0.034, 95% CI 0.005–0.063; p = 0.020) withSWB. Although time did not moderate the association with physical fitness (p = 0.116), this was true for PA only in the secondyear (p = 0.020). In contrast, glycaemic stability did not moderate the associations (p > 0.05). In conclusion, physical fitness andPA are associated with greater SWB in young people with T1DM, which may play a role in the psychological aspects of diseasemanagement., This study was supported by a grant PI21/01238 and PI24/00829 from the Instituto de Salud Carlos III-ERDF (Spain). The project that gave riseto these results received the support of a fellowship form 'Instituto de Salud Carlos III' granted to Jacinto Muñoz-Pardeza (FI22/00329).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Tesis doctoral (DoctoralThesis)

Optimising type 1 diabetes mellitus management in children and adolescents from a non-pharmacological approach based on muscle strengthening activities using an mHealth: Diactive-1 study, Optimización del manejo de la diabetes mellitus tipo 1 en niños y adolescentes desde un enfoque no farmacológico basado en actividades de fortalecimiento muscular utilizando una mHealth: estudio Diactive-1

  • Muñoz Pardeza, Jacinto
El tutor de la tesis es Mikel Izquierdo Redín, Objetivo: Evaluar la asociación de los patrones de movimiento diarios con la estabilidad metabólica y el impacto de intervenciones no farmacológicas, específicamente una intervención de entrenamiento de resistencia con la aplicación Diactive-1, sobre los requerimientos de insulina, la estabilidad glucémica y la composición corporal en niños y adolescentes con diabetes mellitus tipo 1. Método: (1) revisión sistemática con metaanálisis en red bayesiano de ensayos clínicos aleatorizados que evalúan la eficacia de intervenciones no-farmacológicas sobre el control glucémico en jóvenes con diabetes tipo 1; (2) estudio longitudinal observacional de dos años con análisis composicional sobre patrones de movimiento durante 24 horas en niños y adolescentes de la cohorte Diactive-1; y (3) un ensayo controlado aleatorio simple ciego que examina los efectos de una intervención de entrenamiento de resistencia progresiva, administrada de forma remota a través de la aplicación mHealth gamificada Diactive-1, sobre los requisitos de insulina, los resultados glucémicos y la fuerza muscular, así como diferentes parámetros de composición corporal (4). Conclusión: Los resultados demuestran la importancia de aumentar el tiempo dedicado a la actividad física de intensidad moderada a vigorosa a lo largo del día, en lugar de llevar un estilo de vida sedentario, y refuerzan el papel del ejercicio como estrategia terapéutica no-farmacológica. En concreto, Diactive-1 parece ser una herramienta segura y eficaz para reducir los requerimientos de insulina y mejorar la fuerza muscular, destacando los beneficios del entrenamiento de fuerza., Objective: To evaluate the association of daily movement patterns on metabolic stability and the impact of non-pharmacological interventions, specifically a resistance training intervention with the Diactive-1 app, on insulin requirements, glycaemic stability, and body composition in children and adolescents with type 1 diabetes mellitus. Method: (1) a systematic review with a Bayesian network meta-analysis of randomised controlled trials evaluating the effectiveness of non-pharmacological interventions on glycaemic control in youth with type 1 diabetes; (2) a two-year longitudinal observational study applying compositional data analysis to 24-hour movement behaviours in children and adolescents from the Diactive-1 cohort; and (3) a single-blind randomised controlled trial examining the effects of a progressive resistance training intervention, delivered remotely via the gamified mHealth application Diactive-1, on insulin requirements, glycaemic outcomes, and muscular strength, as well as different body composition parameters (4). Conclusion: The findings demonstrate the importance of increasing the amount of time spent engaged in moderate-to-vigorous physical activity throughout the day, rather than a sedentary lifestyle, and reinforce the role of exercise as a non-pharmacological therapeutic strategy. Specifically, Diactive-1 appears to be a safe and effective tool for reducing insulin requirements and improving muscle strength, highlighting the benefits of resistance training., Tesis Doctoral Internacional en el marco de un contrato competitivo predoctoral para la formación inicial de investigadores en ciencias y tecnologías de la salud (PFIS), gestionado por el Instituto de Investigación Sanitaria de Navarra (IdiSNA) y concedido en convocatoria competitiva por el Instituto de Salud Carlos III (FI22/00329), en el contexto del Plan Estratégico de Investigación Científica, Técnica y de Innovación 2021-2023, financiado por el Fondo Europeo de Desarrollo Regional (FEDER). Esta tesis se enmarca en el proyecto de investigación PI21/01238, financiado por la misma entidad., Programa de Doctorado en Ciencias de la Salud (RD 99/2011), Osasun Zientzietako Doktoretza Programa (ED 99/2011)
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Is physical fitness associated with leucocyte telomere length in youth with type 1 diabetes?

  • Muñoz Pardeza, Jacinto
  • López Gil, José Francisco
  • Huerta Uribe, Nidia
  • Hormazábal Aguayo, Ignacio
  • Ojeda-Rodríguez, Ana
  • Martí del Moral, Amelia
  • Izquierdo Redín, Mikel
  • García Hermoso, Antonio
Background: in type 1 diabetes, telomere length (TL) may predict complications and could be influenced by glycaemic control and physical activity, but its relationship with physical fitness in youths remains unexplored. The aim of the study was to assess the association between physical fitness and TL in youth with type 1 diabetes, both at baseline and one year later. Methods: eighty-three children and adolescents (aged 6-18 years; 44.6% girls) with type 1 diabetes from the Diactive-1 Cohort Study were involved in this study. Physical fitness was assessed using spirometry on a cycloergometer (i.e., peak oxygen consumption), dynamometry, and maximal isometric strength (one-repetition maximum [1RM]), and muscle power. Leucocyte TL was assessed using multiplex monochrome real-time quantitative polymerase chain reaction. Results: positive cross-sectional associations were identified between 1RM (unstandardized beta coefficient [B] = 0.042, 95% bias corrected and accelerated [BCa] confidence interval [CI] 0.012-0.069), muscle power (B = 0.056, 95% BCa CI 0.02-0.250), and overall physical fitness (B = 0.043, 95% BCa CI 0.015¿0.071) with TL independent of maturation, glycated haemoglobin, and diabetes duration. However, no associations were observed one year later. Conclusion: higher levels of fitness, particularly muscle strength, may play a role in telomere dynamics in youth with type 1 diabetes, suggesting that strength training exercise could be beneficial. Impact: this is the first study to examine cross-sectional and longitudinal perspectives on the correlation among muscle strength, peak oxygen consumption [VO2peak] and telomere length in youths with type 1 diabetes. Higher physical fitness levels, as assessed by measures such as one-repetition maximum, muscle power, and overall physical fitness, are positively associated with telomere length in youths with type 1 diabetes. Understanding this link could improve management strategies, prioritizing muscle strength training for better long-term health in type 1 diabetes., This study was funded by grant PI21/01238 from the Instituto de Salud Carlos III (Spain) and by CIBER of Obesity Physiology and Nutrition (CB12/03/30002). The project that gave rise to these results received the support of a fellowship form 'Instituto de Salud Carlos III' granted to Jacinto Muñoz-Pardeza (FI22/00329). Dr. Ana Ojeda-Rodriguez is the recipient of a Sara Borrell grant (CD21/00099) from the Instituto de Salud Carlos III. The origin of obtaining results was supported by a scholarship from the 'la Caixa' Foundation awarded to Nidia Huerta Uribe.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Sex-specific thresholds of peak oxygen consumption for detecting cardiometabolic risk in children and adolescents with type 1 diabetes

  • García Hermoso, Antonio
  • Huerta Uribe, Nidia
  • Hormazábal Aguayo, Ignacio
  • Muñoz Pardeza, Jacinto
  • Abreu de Lima, Valderi de
  • Leite, Neiva
  • Nesi-França, Suzana
  • Yáñez-Sepúlveda, Rodrigo
  • Hurtado-Almonácid, Juan
  • Ezzatvar, Yasmin
Aims: To establish sex-specific peak oxygen consumption (VO2peak) thresholds that accurately discriminate cardiometabolic risk (CMR) in children and adolescents with type 1 diabetes and to validate these cut-off points using an independent cohort. Methods: This longitudinal study included 83 participants (aged 8–18 years) with type 1 diabetes from the Diactive-1 cohort. VO2peak was assessed via maximal exercise testing with direct gas analysis, and CMR was calculated using a composite z-score of waist circumference, lipid profile, HbA1c, and blood pressure. VO2peak thresholds for CMR were identified by sex using logistic regression and receiver operating characteristic analysis, and externally validated in a Brazilian cohort (n = 36). A total of 62 individuals completed the 2-year follow-up assessment. Results: Optimal VO2peak thresholds were 40.8 ml/kg/min for boys and 33.7 ml/kg/min for girls, with areas under the curve of 0.71 and 0.78, respectively. Participants below these thresholds had significantly higher lipids and overall CMR. These associations persisted at the two-year follow-up and were confirmed in the Brazilian cohort, which also showed elevated HbA1c among high-risk individuals. Conclusions: Our study supports the clinical utility of these thresholds as a non-invasive marker of metabolic health and reinforce the importance of cardiorespiratory fitness promotion in this population., This study was funded by grant PI21/01238 from the Instituto de Salud Carlos III (Spain) and co-funded by de European Union. The project that gave rise to these results received the support of a fellowship form Instituto de Salud Carlos III granted to Jacinto Muñoz-Pardeza (FI22/00329). Open Access funding provided by Universidad Pública de Navarra.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Evaluating the usability of Diactive-1: mHealth for personalized exercise and education in children and adolescents with type 1 diabetes

  • Hormazábal Aguayo, Ignacio
  • Muñoz Pardeza, Jacinto
  • Huerta Uribe, Nidia
  • Ezzatvar, Yasmin
  • García Hermoso, Antonio
Background: Managing physical activity alongside glucose levels is challenging for children and adolescents with type 1 diabetes mellitus (T1DM). This study aimed to evaluate the usability of the Diactive-1 app, which was designed to support muscle-strengthening training in children and adolescents with T1DM in accordance with guidelines from the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the American Diabetes Association (ADA). Methods: Twenty-seven patients aged 8–18 years with T1DM were randomly selected. Recruitment was conducted through the Pediatric Endocrinology Unit of the University Hospital of Navarra (Spain). All participants were enrolled in a randomized controlled trial and used the Diactive-1 app during the intervention. The study lasted 24 weeks, during which the app provided personalized muscle-strengthening exercise sessions, glucose monitoring, and motivational features such as gamification. Usability of the app was assessed using the User Version of the Mobile Application Rating Scale (uMARS). Results: The Diactive-1 app demonstrated high usability, with an overall quality mean score of 4.33 [standard deviation (SD) =0.36] out of 5.00. uMARS objective domains ratings were: functionality [4.52 (SD =0.40)], aesthetics [4.43 (SD =0.45)], engagement [4.07 (SD =0.51)], information quality [4.29 (SD =0.75)], and subjective quality score was 3.94 (SD =0.61). Usability scores showed no meaningful variation across patient demographics, including sex, age, glycated hemoglobin, engagement in muscle-strengthening activities, and fear of hypoglycemia, suggesting consistent app performance among different user groups. Conclusions: The Diactive-1 app is a promising tool for integrating muscle-strengthening training and educating patients about safe physical exercise into the management of T1DM in children and adolescents. Its high usability and positive user feedback underscore its potential as an effective supportive strategy for managing the disease in this population. Further refinement of personalization features may enhance its effectiveness., This study was funded by a grant PI21/01238 from the Instituto de Salud Carlos III - ERDF (Spain). The project that gave rise to these results received the support of a fellowship form 'Instituto de Salud Carlos III' granted to Jacinto Muñoz-Pardeza (No. FI22/00329).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Association of physical activity patterns with nocturnal hypoglycemia events in youth with type 1 diabetes

  • Hormazábal Aguayo, Ignacio
  • Huerta Uribe, Nidia
  • Muñoz Pardeza, Jacinto
  • Ezzatvar, Yasmin
  • Izquierdo Redín, Mikel
  • García Hermoso, Antonio
Aims This study sought to elucidate the interactions among physical activity (PA) patterns, mean glucose concentrations, and the incidence of nocturnal hypoglycemia events in children and adolescents with type 1 diabetes, examining the moderating influence of daily dosage on these associations.Methods Eighty-two participants aged 6 to 18 years (43.9% girls) from the Diactive-1 Cohort Study, diagnosed with type 1 diabetes, were included. Data collection involved continuous glucose monitoring, accelerometry to assess real-world PA, as well as documentation of daily insulin doses and carbohydrate counting over the same 7 days.Results A total of 19 participants experienced at least 1 nocturnal hypoglycemia event over a span of 574 measurement days (106 days with and 451 days without nocturnal hypoglycemia). Higher levels of vigorous PA (VPA) were associated with lower same-day mean glucose levels (P = .014). Additionally, higher levels of moderate PA (P = .023), VPA (P = .011), and moderate-to-vigorous PA (P = .010) were associated with a greater number of nocturnal hypoglycemia events. Specifically, a significant association was identified between VPA and nocturnal hypoglycemia events when the daily insulin dose was at or above 1.04 units per kilogram of body weight per day (P = .016).Conclusion Daily VPA is associated with glucose reductions, potentially leading to more hypoglycemic episodes, particularly when there is an excess of daily insulin. This highlights the need for careful insulin management in children and adolescents with type 1 diabetes engaging in VPA., This study was funded by grant PI21/01238 from the Instituto de Salud Carlos III-ERDF (Spain). The project that gave rise to these results received the support of a fellowship form Instituto de Salud Carlos III granted to J.M.P. (FI22/00329).